The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Where does the world get its silver? In 2023, silver mines produced 830.5 million ounces of silver. That total is projected to decline by about 1 percent to 823.5 million ounces in 2024.

A fresh coat of paint can have a bold, immediate impact on the look and feel of any interior space — the challenge is picking the right colour from all the options available, ranging from ...